HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jae-Sung Kim Selected Research

HEPES

4/2012Mitochondrial permeability transition in rat hepatocytes after anoxia/reoxygenation: role of Ca2+-dependent mitochondrial formation of reactive oxygen species.
5/2006Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion.
6/2004Nitric oxide protects rat hepatocytes against reperfusion injury mediated by the mitochondrial permeability transition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jae-Sung Kim Research Topics

Disease

68Neoplasms (Cancer)
01/2022 - 10/2002
28Rectal Neoplasms (Rectal Cancer)
08/2021 - 10/2002
15Breast Neoplasms (Breast Cancer)
08/2022 - 01/2010
15Ischemia
09/2021 - 10/2002
14Prostatic Neoplasms (Prostate Cancer)
10/2022 - 11/2012
13Inflammation (Inflammations)
05/2021 - 11/2011
12Lung Neoplasms (Lung Cancer)
01/2022 - 09/2003
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2019 - 03/2013
10Neoplasm Metastasis (Metastasis)
01/2021 - 07/2010
10Osteoarthritis
01/2021 - 10/2010
9Mitochondrial Diseases (Mitochondrial Disease)
01/2021 - 11/2004
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 10/2009
7Squamous Cell Carcinoma of Head and Neck
05/2022 - 01/2015
7Reperfusion Injury
01/2021 - 06/2004
7Mouth Neoplasms (Oral Cancer)
10/2017 - 01/2013
6Hepatocellular Carcinoma (Hepatoma)
07/2022 - 09/2008
6Infections
09/2020 - 12/2006
6Pain (Aches)
11/2015 - 10/2010
6Laryngeal Neoplasms (Laryngeal Cancer)
02/2015 - 07/2010
6Necrosis
01/2013 - 10/2002
5Head and Neck Neoplasms (Head and Neck Cancer)
06/2021 - 07/2011
5Carcinogenesis
07/2019 - 02/2014
5Hypoxia (Hypoxemia)
10/2018 - 12/2006
5Intervertebral Disc Degeneration
09/2013 - 12/2010
4Carcinoma (Carcinomatosis)
06/2021 - 04/2003
4Body Weight (Weight, Body)
06/2018 - 03/2015
4Edema (Dropsy)
06/2018 - 09/2017
4Fatty Liver
01/2017 - 08/2013
3Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2021 - 10/2009
3Tuberculosis (Tuberculoses)
05/2021 - 01/2017
3Sepsis (Septicemia)
04/2020 - 01/2016
3Osteosarcoma (Osteogenic Sarcoma)
01/2019 - 01/2014
3Brain Neoplasms (Brain Tumor)
02/2018 - 11/2015
3Adenocarcinoma
12/2017 - 10/2009
3Hyperalgesia
11/2015 - 01/2011
3Chronic Pain
10/2011 - 10/2010
2Fatigue
06/2022 - 07/2010
2Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 09/2012
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 10/2016
2Colonic Neoplasms (Colon Cancer)
01/2020 - 02/2013

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2002
11CytokinesIBA
07/2021 - 10/2010
9Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2012
9Biological ProductsIBA
01/2020 - 10/2010
9Pharmaceutical PreparationsIBA
01/2020 - 09/2003
7Reactive Oxygen Species (Oxygen Radicals)IBA
05/2021 - 12/2004
7CaspasesIBA
07/2019 - 01/2013
7MicroRNAs (MicroRNA)IBA
06/2018 - 07/2011
6Death Domain ReceptorsIBA
02/2020 - 02/2014
6Phosphotransferases (Kinase)IBA
01/2020 - 06/2004
6Small Interfering RNA (siRNA)IBA
01/2019 - 02/2014
6Adenosine Triphosphate (ATP)IBA
01/2017 - 10/2002
5Hormones (Hormone)IBA
02/2020 - 03/2016
5Caspase 3 (Caspase-3)IBA
05/2018 - 01/2013
4Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
11/2019 - 02/2014
4CarrageenanIBA
06/2018 - 09/2017
4Morphine (MS Contin)FDA LinkGeneric
11/2015 - 12/2006
4BuffersIBA
04/2012 - 06/2004
3Therapeutic UsesIBA
12/2021 - 10/2018
3Cisplatin (Platino)FDA LinkGeneric
10/2021 - 09/2012
3Interleukin-6 (Interleukin 6)IBA
07/2021 - 11/2011
325-hydroxycholesterolIBA
05/2020 - 02/2020
3OxysterolsIBA
05/2020 - 02/2020
3Carcinoembryonic AntigenIBA
04/2020 - 02/2011
3Peptides (Polypeptides)IBA
01/2020 - 01/2016
3LipidsIBA
01/2020 - 07/2013
3ErbB Receptors (EGF Receptor)IBA
07/2019 - 07/2006
3DAPIIBA
01/2019 - 02/2014
3Cytochromes c (Cytochrome c)IBA
05/2018 - 10/2002
3LigandsIBA
01/2018 - 01/2013
3KetorolacIBA
11/2015 - 01/2011
3Pregabalin (Lyrica)FDA Link
11/2015 - 01/2011
3Celecoxib (Celebrex)FDA Link
11/2015 - 01/2011
3IronIBA
07/2015 - 11/2008
33' Untranslated Regions (3' UTR)IBA
04/2014 - 02/2014
3Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2012 - 10/2002
3HEPESIBA
04/2012 - 06/2004
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2011 - 01/2011
2Protons (Proton)IBA
07/2022 - 01/2016
2GemcitabineFDA Link
10/2021 - 09/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2021 - 10/2002
2InterleukinsIBA
07/2021 - 12/2012
2Prostate-Specific Antigen (Semenogelase)IBA
01/2021 - 01/2014
2LipopolysaccharidesIBA
12/2020 - 09/2013
2Sirtuin 3IBA
04/2020 - 01/2020
2CholesterolIBA
02/2020 - 01/2020
2Estrogens (Estrogen)FDA Link
02/2020 - 07/2019

Therapy/Procedure

45Radiotherapy
10/2022 - 04/2003
23Chemoradiotherapy
10/2021 - 07/2010
20Therapeutics
01/2022 - 12/2010
15Drug Therapy (Chemotherapy)
10/2021 - 04/2003
15Neoadjuvant Therapy
01/2021 - 10/2002
8Prostatectomy (Retropubic Prostatectomy)
10/2022 - 10/2015
7Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
08/2022 - 02/2015
6Transplantation
01/2021 - 12/2011
4Adjuvant Radiotherapy
12/2017 - 01/2013
3Proctectomy
01/2021 - 09/2008
3Molecular Targeted Therapy
01/2020 - 01/2016
3Adjuvant Chemotherapy
01/2015 - 02/2013
2Resuscitation
04/2020 - 01/2018